Federal Circuit Slams Purdue With Inequitable Conduct Finding In OxyContent Patent Suit

Law360, New York (June 7, 2005, 12:00 AM EDT) -- In a major setback for Purdue Pharma, Endo Pharmaceutical Holdings Inc. has won an appeals court ruling allowing it to sell a generic version of the painkiller OxyContin.

The U.S. Court of Appeals for the Federal Circuit upheld a decision that three patents held by Purdue Pharma LP are unenforceable due to inequitable conduct before the U.S. Patent and Trademark Office.

The decision upholds a January 2004 ruling from U.S. District Court Judge Sidney Stein with the Southern District of New York.

Judge Stein found that...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.